Anika Therapeutics, Inc.: accounts_receivable

Value{"amount": 34627000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2022-12-01)
Statussuperseded
EntityAnika Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001171843-23-003106
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000898437/accounts-receivable/2022-12-01 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/8baf9a1e-d3f2-4997-a36c-0f2f3075318a

History